Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation
Katarina Le Blanc(Karolinska University Hospital), Olle Ringdén(Karolinska Institutet)
Cited by 481
Related Papers
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?
|Stem Cells|2014|407
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
|Stem Cells|2012|371
Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression
|Stem Cells|2016|344
Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice
|Bone Marrow Transplantation|2013|310